PADRÕES DE USO DE VOXELOTOR EM UM ESTUDO MULTICÊNTRICO DO MUNDO REAL DE PACIENTES COM DOENÇA FALCIFORME
B Andemariama, M Idowub, N Shahc, R Drachtmand, A Glarose, M Achebef, A Nerog, F Montealegr-Golcherh, S Curtisi, C Minnitii
a New England Sickle Cell Institute, University of Connecticut Health, Farmington, Estados Unidos
b University of Texas Health McGovern Medical School, Houston, Estados Unidos
c Duke University School of Medicine, Durham, Estados Unidos
d Rutgers Medical School, New Brunswick, Estados Unidos
e Division of Pediatric Hematology/Oncology, Central Michigan University, Detroit, Estados Unidos
f Brigham and Women's Hospital, Harvard Medical School, Boston, Estados Unidos
g University of Texas Southwestern Medical Center, Dallas, Estados Unidos
h Pfizer Inc, New York, Estados Unidos
i Albert Einstein College of Medicine, Bronx, Estados Unidos
Ver másRead
301
Timeswas read the article
158
Total PDF
143
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 25 | 17 | 42 |
| 2024 April | 27 | 13 | 40 |
| 2024 March | 28 | 24 | 52 |
| 2024 February | 17 | 26 | 43 |
| 2024 January | 14 | 13 | 27 |
| 2023 December | 11 | 23 | 34 |
| 2023 November | 14 | 31 | 45 |
| 2023 October | 7 | 11 | 18 |
